Now showing items 1-2 of 2

    • The cost of multiple sclerosis in Norway 

      Svendsen, Bjørn; Myhr, Kjell-Morten; Nyland, Harald Inge; Aarseth, Jan Harald (Springer, 2010-11-16)
      Health economic aspects have been increasingly important during introduction of new treatments for multiple sclerosis. As a partial response for Norway, a costof- illness study was carried out to estimate the yearly ...
      Peer reviewedJournal article
    • Prognostic relevance of an epigenetic biomarker panel in sentinel lymph nodes from colon cancer patients 

      Lind, Guro Elisabeth; Guriby, Marianne; Ahlquist, Terje Cruickshank; Hussain, Israr; Jeanmougin, Marine; Søreide, Kjetil; Kørner, Hartwig; Lothe, Ragnhild A; Nordgård, Oddmund (BioMed Central, 2017-09-05)
      Background: Patients with early colorectal cancer (stages I–II) generally have a good prognosis, but a subgroup of 15–20% experiences relapse and eventually die of disease. Occult metastases have been suggested ...
      Journal article